e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Risk factors for asthma versus asthma control
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Expression of surface markers on peripheral CD4
+
CD25
high
T cells in patients with atopic asthma: role of inhaled corticosteroid
Y. Kaisheng, Z. Qian, H. Mao, Z. Xilong (Nanjing/Jiangsu, China)
Source:
Annual Congress 2008 - Risk factors for asthma versus asthma control
Session:
Risk factors for asthma versus asthma control
Session type:
Thematic Poster Session
Number:
3708
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Kaisheng, Z. Qian, H. Mao, Z. Xilong (Nanjing/Jiangsu, China). Expression of surface markers on peripheral CD4
+
CD25
high
T cells in patients with atopic asthma: role of inhaled corticosteroid. Eur Respir J 2008; 32: Suppl. 52, 3708
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Reduced numbers of circulating CD4
+
CD25
high
FOXP3
+
regulatory T cells in patients with allergic asthma
Source: Annual Congress 2008 - Understanding airway inflammation
Year: 2008
T-regulatory cells blood content in patients with asthma exacerbation
Source: Annual Congress 2011 - T-cell subsets
Year: 2011
Low number of regulatory T cells in bronchial asthma: association with inflammatory cytokines
Source: Annual Congress 2009 - Infections, immunity and inflammation
Year: 2009
Increased levels of CD4+CD25high and CD4+FoxP3+ T-regulatory cells (Tregs) in patients with different severity of bronchial asthma (BA)
Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD
Year: 2011
T regulatory cells decrease before asthma exacerbations
Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma
Year: 2008
Regulatory T cells and L-selectin in severe asthmatic patients treated with mepolizumab.
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020
Infiltration of mast cells with increased IgE-receptor expression in peripheral lung of patients with uncontrolled asthma
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010
Increased T helper lymphocytes and macrophages in peripheral airways of patients with uncontrolled asthma
Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation
Year: 2010
Gamma/delta T cells regulate airways disease during rhinovirus-induced asthma exacerbations
Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections
Year: 2011
Different profiles of lung and systemic regulatory T cells in mild asthmatics
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010
The role of regulatory T cells in differentiating asthma from COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 373s
Year: 2007
Omalizumab enhances the percentage of GARP cells in both regulatory and terminally differentiated effector Th cells in severe allergic asthmatics
Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Year: 2018
Increase of both blood CXCR3+ and CCR4+ helper T cells associated with severity of asthma
Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma
Year: 2005
Steroid insensitivity of airway T lymphocytes in COPD patients
Source: Annual Congress 2009 - Pathology and immunology of COPD
Year: 2009
T cell cytokine profiles in childhood asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 391s
Year: 2002
Study of the effect of IL-4 and IFN-γ on Th1/Th2 cells and mast cells in allergic asthma patients
Source: Eur Respir J 2001; 18: Suppl. 33, 271s
Year: 2001
Cytokine production profile of T-lymphocytes and frequence of regulatory T-cells in patients with allergic asthma receiving anti-IgE therapy
Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Year: 2011
Follicular T helper and Breg cell balance in severe allergic asthma before and after omalizumab therapy
Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD
Year: 2021
Comparative characteristics of regulatory T cells populations between patients with bronchial asthma (BA) and COPD
Source: Annual Congress 2011 - T-cell subsets
Year: 2011
The expression of CD39 mRNA is altered in peripheral blood of patients with allergic asthma
Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept